Home > Income Statement > CONCORD BIOTECH

CONCORD BIOTECH
Revenue

    Back to Income Statement
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹1,017 Cr₹853 Cr₹713 Cr₹617 Cr₹512 Cr

What is the latest Revenue of CONCORD BIOTECH ?

The latest Revenue ratio of CONCORD BIOTECH is ₹1,017 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹1,017 Cr
Mar2023₹853 Cr
Mar2022₹713 Cr
Mar2021₹617 Cr
Mar2020₹512 Cr

How is Revenue of CONCORD BIOTECH Trending?

Years Revenue % Change
Mar2024 ₹1,017 Cr
19.20
Mar2023 ₹853 Cr
19.67
Mar2022 ₹713 Cr
15.56
Mar2021 ₹617 Cr
20.42
Mar2020 ₹512 Cr -

Compare Revenue of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹16,104.7 Cr 7.1% -7.4% -2.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,648.0 Cr -4.9% 2.1% 15.5% Stock Analytics
DIVIS LABORATORIES ₹159,310.0 Cr -2.2% 9.3% 50.5% Stock Analytics
CIPLA ₹119,410.0 Cr -4.2% 4.5% 4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,189.0 Cr -4.4% -4.5% 17.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,496.4 Cr -1.4% 4.2% -8.8% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

7.1%

-7.4%

-2.7%

SENSEX

-1.3%

4.1%

7.6%


You may also like the below Video Courses